Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data
Lasse Rehné Jensen(Herlev Hospital), Christian Mirian(Copenhagen University Hospital), Tiit Mathiesen(University of Copenhagen), Morten Ziebell(University of Copenhagen), Helle Broholm(Copenhagen University Hospital), Tina Nørgaard Munch(Statens Serum Institut), Bjarne Winther Kristensen(University of Copenhagen), Julia Furtner(Medical University of Vienna), Thomas Graillon(Inserm), Óscar Arrieta(Instituto Nacional de Cancerología), Alejandro Ruíz-Patiño(Foundation for Clinical and Applied Cancer Research), Martin A. Walter(Unité de Nutrition Humaine), Daniela A. Bota(University of California, Irvine), Andrea Daniela Maier(University of Copenhagen), Matthias Preusser(Medical University of Vienna), Ulrich Roeckle(Kantonsspital Aarau), David Scheie(Copenhagen University Hospital), Atle Lomstein(Aarhus University Hospital), Kåre Fugleholm(University of Copenhagen), Maya Hrachova(Haukeland University Hospital), Paul M. Clément(Universitair Ziekenhuis Leuven), Roberta Rudà, Jane Skjøth‐Rasmussen(University of Cambridge)
Cited by 8
Related Papers
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
|Thyroid|2016|2.8k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994